QIPT Issues Q2 2025 Financial Release; Includes Non-GAAP Measures

Rhea-AI Filing Summary

Quipt Home Medical Corp. announced a press release furnished on August 11, 2025 reporting its financial results for the quarter ended June 30, 2025. The filing states the press release is furnished as Exhibit 99.1 and that the information is furnished, not filed, under the Exchange Act.

The company discloses the press release includes Non-GAAP financial measures along with GAAP comparatives and reconciliations and explains management believes these measures provide useful supplemental information. The 8-K is signed by CFO Hardik Mehta and identifies Quipt as an emerging growth company incorporated in British Columbia, Canada.

Insights

Financial Analyst

TL;DR: The 8-K furnishes Q2 2025 results press release but provides no financial figures, limiting immediate analytical conclusions.

The filing confirms a press release for the quarter ended June 30, 2025 was furnished as Exhibit 99.1 and that it contains Non-GAAP measures reconciled to GAAP. From an analyst perspective, the filing is a routine disclosure that signals upcoming data availability rather than delivering material content itself. Because no revenue, profit, guidance, or balance-sheet items are included in the 8-K text, investors must review Exhibit 99.1 to assess performance and material impact.

Corporate Governance Expert

TL;DR: This 8-K meets disclosure and formatting expectations but is procedural; it furnishes, rather than files, the earnings release.

The document appropriately notes the press release is furnished and not deemed filed, which limits the Exchange Act liabilities associated with the content. The explicit inclusion of Non-GAAP measures with reconciliations reflects compliance with Regulation G disclosure practices. The filing identifies the company as an emerging growth company and is signed by the CFO, indicating standard internal controls over disclosure timing. Without the exhibit text, governance implications are limited.

00-00000000001540013false00015400132025-08-112025-08-11

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

​

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

​

August 11, 2025

Date of Report (Date of earliest event reported)

Quipt Home Medical Corp.

(Exact name of registrant as specified in its charter)

British Columbia, Canada

(State or other jurisdiction of incorporation)

​

001-40413		N/A
(Commission File Number)	​	(IRS Employer Identification No.)

​

1019 Town Drive		​
Wilder, Kentucky	​	41076
(Address of principal executive offices)	​	(Zip Code)

​

(859) 878-2220

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Shares, without Par Value	​	QIPT	​	The Nasdaq Capital Market
​	​	​	​	Toronto Stock Exchange

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company   ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

​

​

​

​

Item 2.02. Results of Operations and Financial Condition.

On August 11, 2025, Quipt Home Medical Corp. (the “Company”) issued a press release regarding the Company’s financial results for the quarter ended June 30, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

The information in this Item 2.02, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. The press release includes Non-GAAP financial measures as defined in Regulation G.

​

Use of Non-GAAP Financial Information:

The press release also includes the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), information reconciling the Non-GAAP financial measures to the GAAP financial measures and a discussion of the reasons why the Company’s management believes that presentation of the Non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations. The Non-GAAP financial measures presented therein should be considered in addition to, not as a substitute for, or superior to, financial measures calculated and presented in accordance with GAAP.

​

​

​

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
​	​	​
99.1	​	Press Release by Quipt Home Medical Corp. dated August 11, 2025.
​	​	​
104	​	Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.

​

​

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​		​
​		Quipt Home Medical Corp.
​		​
Date:	August 11, 2025	By:	/s/ Hardik Mehta
​		​	Hardik Mehta
​		​	Chief Financial Officer

​

​

​

FAQ

When did Quipt (QIPT) report results for the quarter ended June 30, 2025?

Quipt issued a press release dated August 11, 2025 reporting results for the quarter ended June 30, 2025, furnished as Exhibit 99.1.

Does the 8-K include the company’s financial numbers for Q2 2025?

No. The 8-K states a press release containing the results is furnished as Exhibit 99.1, but the filing text itself does not include financial figures.

Are Non-GAAP financial measures included in the disclosed press release?

Yes. The filing states the press release includes Non-GAAP financial measures and provides reconciliations to the most directly comparable GAAP measures.

Is the press release considered "filed" under the Exchange Act?

No. The 8-K explicitly states the information and Exhibit 99.1 are furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.

What is Quipt’s corporate status and who signed the 8-K?

Quipt is incorporated in British Columbia, Canada, is designated an emerging growth company, and the form is signed by Hardik Mehta, Chief Financial Officer.